In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-11 of 11 for your search:
Drug:  cediranib maleate
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02015, S0905, CDR0000665415, U10CA032102, SWOG-S0905, NCT01064648
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02938, DFCI IRB 09-293, U01CA062490, N01CM00071, NCT01116648
3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02530, 10-182-B, UCCRC-10-182-B, CDR0000685236, N01CM00071, 8317, NCT01208051
4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00127, 05-254, N02CO12400, CDR0000460079, MGH-05-254, NCI-7105, 7105, NCT00305656
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02012, U10CA021661, CDR0000665163, RTOG 0837, RTOG-0837-ACRIN-6689, NCT01062425
6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090192, 09-C-0192, NCT00942877
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CRUK-C-2009-01, CRUK CIRCCa, CIRCCa, EUDRACT-2009-011542-25, ISRCTN-23516549, EU-21080, ZENECA-CRUK-C-2009-01, NCT01229930
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: ICR-CTSU/2010/10027, 2010-021163-33, CRUK/10/021, ISRCTN63733470, ISSRECE0036, NCT01337401
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 16 to 20
Sponsor: NCI
Protocol IDs: 110200, 11-C-0200, NCT01391962
10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09_DOG03_184, 2009-016524-31, NCT01160926
11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 years and over
Sponsor: NCI
Protocol IDs: NCI-2012-02906, MC1012, U01CA069912, CDR0000700596, MAYO-MC1012, 8810, NCT01364051
New Search